Operators in the Blood and Organ Banks industry grapple with steadily rising demand for organs and blood. Each year, there is a shortage of organs for needed for life-saving transplants. Despite high demand for certain organs and blood products, revenue hinges on donations. Consequently, due to decreasing demand and supply constraints, industry revenue is expected to stagnate over the five years to 2017. Over the five years to 2022, revenue is expected to slowly grow. Medical research is expected to drive demand for blood products as national institutes develop vaccines for global epidemics such as the Zika virus.
This industry includes companies that primarily collect, store and distribute human blood, blood products and human organs.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.